Literature DB >> 23571666

Understanding neurological disease mechanisms in the era of epigenetics.

Irfan A Qureshi1, Mark F Mehler.   

Abstract

The burgeoning field of epigenetics is making a significant impact on our understanding of brain evolution, development, and function. In fact, it is now clear that epigenetic mechanisms promote seminal neurobiological processes, ranging from neural stem cell maintenance and differentiation to learning and memory. At the molecular level, epigenetic mechanisms regulate the structure and activity of the genome in response to intracellular and environmental cues, including the deployment of cell type-specific gene networks and those underlying synaptic plasticity. Pharmacological and genetic manipulation of epigenetic factors can, in turn, induce remarkable changes in neural cell identity and cognitive and behavioral phenotypes. Not surprisingly, it is also becoming apparent that epigenetics is intimately involved in neurological disease pathogenesis. Herein, we highlight emerging paradigms for linking epigenetic machinery and processes with neurological disease states, including how (1) mutations in genes encoding epigenetic factors cause disease, (2) genetic variation in genes encoding epigenetic factors modify disease risk, (3) abnormalities in epigenetic factor expression, localization, or function are involved in disease pathophysiology, (4) epigenetic mechanisms regulate disease-associated genomic loci, gene products, and cellular pathways, and (5) differential epigenetic profiles are present in patient-derived central and peripheral tissues.

Entities:  

Mesh:

Year:  2013        PMID: 23571666      PMCID: PMC4465100          DOI: 10.1001/jamaneurol.2013.1443

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  25 in total

1.  Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.

Authors:  Stephan Gehrke; Yuzuru Imai; Nicholas Sokol; Bingwei Lu
Journal:  Nature       Date:  2010-07-29       Impact factor: 49.962

2.  Variants on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population.

Authors:  Weili Zhang; Yu Chen; Peng Liu; Jingzhou Chen; Lei Song; Yue Tang; Yuyao Wang; Jibin Liu; Frank B Hu; Rutai Hui
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

3.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.

Authors:  James R Tollervey; Tomaž Curk; Boris Rogelj; Michael Briese; Matteo Cereda; Melis Kayikci; Julian König; Tibor Hortobágyi; Agnes L Nishimura; Vera Zupunski; Rickie Patani; Siddharthan Chandran; Gregor Rot; Blaž Zupan; Christopher E Shaw; Jernej Ule
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

4.  Huntingtin regulates RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued.

Authors:  Masahito Shimojo
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

5.  Role of exosomes/microvesicles in the nervous system and use in emerging therapies.

Authors:  Charles Pin-Kuang Lai; Xandra Owen Breakefield
Journal:  Front Physiol       Date:  2012-06-27       Impact factor: 4.566

6.  An epigenetic blockade of cognitive functions in the neurodegenerating brain.

Authors:  Johannes Gräff; Damien Rei; Ji-Song Guan; Wen-Yuan Wang; Jinsoo Seo; Krista M Hennig; Thomas J F Nieland; Daniel M Fass; Patricia F Kao; Martin Kahn; Susan C Su; Alireza Samiei; Nadine Joseph; Stephen J Haggarty; Ivana Delalle; Li-Huei Tsai
Journal:  Nature       Date:  2012-02-29       Impact factor: 49.962

7.  Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.

Authors:  Céline Bellenguez; Steve Bevan; Andreas Gschwendtner; Chris C A Spencer; Annette I Burgess; Matti Pirinen; Caroline A Jackson; Matthew Traylor; Amy Strange; Zhan Su; Gavin Band; Paul D Syme; Rainer Malik; Joanna Pera; Bo Norrving; Robin Lemmens; Colin Freeman; Renata Schanz; Tom James; Deborah Poole; Lee Murphy; Helen Segal; Lynelle Cortellini; Yu-Ching Cheng; Daniel Woo; Michael A Nalls; Bertram Müller-Myhsok; Christa Meisinger; Udo Seedorf; Helen Ross-Adams; Steven Boonen; Dorota Wloch-Kopec; Valerie Valant; Julia Slark; Karen Furie; Hossein Delavaran; Cordelia Langford; Panos Deloukas; Sarah Edkins; Sarah Hunt; Emma Gray; Serge Dronov; Leena Peltonen; Solveig Gretarsdottir; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Kari Stefansson; Giorgio B Boncoraglio; Eugenio A Parati; John Attia; Elizabeth Holliday; Chris Levi; Maria-Grazia Franzosi; Anuj Goel; Anna Helgadottir; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Audrey Duncanson; Janusz Jankowski; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Richard C Trembath; Ananth C Viswanathan; Nicholas W Wood; Bradford B Worrall; Steven J Kittner; Braxton D Mitchell; Brett Kissela; James F Meschia; Vincent Thijs; Arne Lindgren; Mary Joan Macleod; Agnieszka Slowik; Matthew Walters; Jonathan Rosand; Pankaj Sharma; Martin Farrall; Cathie L M Sudlow; Peter M Rothwell; Martin Dichgans; Peter Donnelly; Hugh S Markus
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

8.  HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage.

Authors:  Jin Young Kim; Siming Shen; Karen Dietz; Ye He; Owain Howell; Richard Reynolds; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2009-12-27       Impact factor: 24.884

9.  Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.

Authors:  Chiara Zuccato; Nikolai Belyaev; Paola Conforti; Lezanne Ooi; Marzia Tartari; Evangelia Papadimou; Marcy MacDonald; Elisa Fossale; Scott Zeitlin; Noel Buckley; Elena Cattaneo
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

10.  The accessible chromatin landscape of the human genome.

Authors:  Robert E Thurman; Eric Rynes; Richard Humbert; Jeff Vierstra; Matthew T Maurano; Eric Haugen; Nathan C Sheffield; Andrew B Stergachis; Hao Wang; Benjamin Vernot; Kavita Garg; Sam John; Richard Sandstrom; Daniel Bates; Lisa Boatman; Theresa K Canfield; Morgan Diegel; Douglas Dunn; Abigail K Ebersol; Tristan Frum; Erika Giste; Audra K Johnson; Ericka M Johnson; Tanya Kutyavin; Bryan Lajoie; Bum-Kyu Lee; Kristen Lee; Darin London; Dimitra Lotakis; Shane Neph; Fidencio Neri; Eric D Nguyen; Hongzhu Qu; Alex P Reynolds; Vaughn Roach; Alexias Safi; Minerva E Sanchez; Amartya Sanyal; Anthony Shafer; Jeremy M Simon; Lingyun Song; Shinny Vong; Molly Weaver; Yongqi Yan; Zhancheng Zhang; Zhuzhu Zhang; Boris Lenhard; Muneesh Tewari; Michael O Dorschner; R Scott Hansen; Patrick A Navas; George Stamatoyannopoulos; Vishwanath R Iyer; Jason D Lieb; Shamil R Sunyaev; Joshua M Akey; Peter J Sabo; Rajinder Kaul; Terrence S Furey; Job Dekker; Gregory E Crawford; John A Stamatoyannopoulos
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  21 in total

1.  SMMDB: a web-accessible database for small molecule modulators and their targets involved in neurological diseases.

Authors:  Subodh Kumar Mishra; Neha Jain; Uma Shankar; Arpita Tawani; Amit Mishra; Amit Kumar
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

Review 2.  Nutrition, the brain and cognitive decline: insights from epigenetics.

Authors:  M J Dauncey
Journal:  Eur J Clin Nutr       Date:  2014-09-03       Impact factor: 4.016

Review 3.  Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 4.  Gestational hypoxia and epigenetic programming of brain development disorders.

Authors:  Qingyi Ma; Fuxia Xiong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-09-26       Impact factor: 7.851

Review 5.  Epigenetics and Epilepsy.

Authors:  David C Henshall; Katja Kobow
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-05       Impact factor: 6.915

Review 6.  Epigenetic mechanisms underlying nervous system diseases.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Handb Clin Neurol       Date:  2018

Review 7.  Clinical application of next-generation sequencing to the practice of neurology.

Authors:  Jessica Rexach; Hane Lee; Julian A Martinez-Agosto; Andrea H Németh; Brent L Fogel
Journal:  Lancet Neurol       Date:  2019-05       Impact factor: 44.182

Review 8.  Sex, epilepsy, and epigenetics.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurobiol Dis       Date:  2014-07-04       Impact factor: 5.996

9.  RIT2 Polymorphisms: Is There a Differential Association?

Authors:  Babak Emamalizadeh; Javad Jamshidi; Abolfazl Movafagh; Mina Ohadi; Mahmoud Shekari Khaniani; Somayyeh Kazeminasab; Akbar Biglarian; Shaghayegh Taghavi; Marzieh Motallebi; Atena Fazeli; Azadeh Ahmadifard; Gholam-Ali Shahidi; Peyman Petramfar; Neda Shahmohammadibeni; Tahereh Dadkhah; Ehteram Khademi; Abbas Tafakhori; Ali Khaligh; Tannaz Safaralizadeh; Ali Kowsari; Arash Mirabzadeh; Amir Ehtesham Shafiei Zarneh; Mehdi Khorrami; Parasto Shokraeian; Mohammad Javad Soltani Banavandi; Behnam Safarpour Lima; Monavvar Andarva; Elham Alehabib; Minoo Atakhorrami; Hossein Darvish
Journal:  Mol Neurobiol       Date:  2016-03-03       Impact factor: 5.590

Review 10.  Epigenetics of sleep and chronobiology.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.